SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently under intense selling pressure as investors weigh market sentiment triggered by Michael Burrys high-profile, albeit deleted, social media critique comparing the company to Anthropic. While the community remains deeply divided, with some investors aggressively buying the dip on the belief that Palantirs proprietary data ontology remains an irreplaceable enterprise moat, others are pointing to bearish technicals and broader concerns regarding valuation in the software sector.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing intense trading activity as investors react to aggressive analyst price target hikes and speculation regarding a potential stock split. The community remains deeply divided, with bulls pointing to the sustained demand for memory chips in AI infrastructure, while skeptical traders and short sellers raise concerns about a parabolic valuation bubble reminiscent of past market manias.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow ($NOW) is facing intense downward pressure as investors rotate out of software stocks, driven by fears that AI-native competitors could disrupt traditional enterprise subscription models. While some investors see the pullback as an opportunistic entry point given the company's strong long-term fundamentals and enterprise retention, others are avoiding the stock due to bearish technical momentum and lingering concerns over its valuation multiple.

Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on April 27, 2023 and is headquartered in New York, NY.

Aimei Health Technology Co Ltd

Aimei Health Technology is currently experiencing intense retail-driven volatility as traders speculate on a potential short squeeze fueled by low-float characteristics and historical patterns of rapid price spikes. The conversation is heavily focused on the stock's tendency for frequent halts and aggressive momentum, with many community members comparing the move to previous sector runners while others warn of the inherent risks associated with its highly volatile, catalyst-dependent nature.

WorldFinancial

WorldFinancial (WLFI) is currently at the center of intense debate as traders react to political scrutiny, potential institutional partnerships, and upcoming events at Mar-a-Lago, fueling a volatile environment. The community is sharply divided between those viewing the price volatility as a strategic accumulation opportunity ahead of platform developments and others expressing concerns over leadership involvement and regulatory investigations.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is currently facing significant investor debate over whether its massive At-the-Market (ATM) financing program is suppressing price action or if the company is simply awaiting its next major hyperscaler deal to unlock value. While some community members are frustrated by the stock's relative underperformance compared to peers like Nebius and TeraWulf, others remain focused on the long-term potential of the company's 1.4GW Sweetwater capacity and its pivot toward large-scale AI infrastructure.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is trending as a nostalgic meme coin that leverages its history dating back to early Bitcoin-era forum jokes to build community conviction. Supporters are actively discussing its potential for mass adoption and its role as a cultural parody, while skeptics continue to debate its long-term viability against established assets.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently at the center of a major market debate, driven by institutional re-ratings as the company shifts from a niche launch provider to a vertically integrated defense prime contractor. While the community remains hyper-focused on the company's consistent orbital execution and its aggressive expansion into high-margin defense programs, short-term price action is being heavily influenced by sector-wide volatility, ongoing dilution concerns, and intense speculation regarding a potential SpaceX IPO.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is seeing intense retail and algorithmic interest as it rallies amidst significant volatility and speculative chatter regarding its semiconductor burn-in technology and AI infrastructure role. Investors are sharply divided, with some betting on a parabolic squeeze driven by high backlog and hyperscaler demand, while others caution that the current valuation is detached from fundamentals and point to dilution risks.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is currently facing intense scrutiny as investors weigh its aggressive share buyback strategy and potential for a strategic turnaround against ongoing concerns regarding market volatility, competitive pressures, and class-action lawsuits. The community remains deeply divided, with many long-term holders expressing frustration over the lack of communication from the new leadership, while others look for catalysts in potential M&A activity or internal cost-cutting measures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know

AC Immune stock gains after expansion of its agreement with LLY, adding next-generation Tau Morphomer candidates and boosting long-term Alzheimer's strategy.

Soleno Therapeutics Stock Rallies 56.4% in a Week: Here's Why

SLNO shares surge as Neurocrine inks $2.9B cash deal to acquire it at $53 a share, adding Vykat XR and expanding its rare disease and endocrinology portfolio.

SNY's Lunsekimig Succeeds in Asthma & CRSwNP Studies, Fails in Eczema

Sanofi posts strong mid-stage results for lunsekimig in asthma and CRSwNP but a setback in atopic dermatitis clouds the broader clinical picture.

IMVT Stock Falls 2.4% as Batoclimab Misses Late-Stage Study Endpoints

Immunovant slips 2.4% after batoclimab misses key phase III endpoints in thyroid eye disease trials, despite stable safety and signs of biological activity.

RARE Rises as FDA Accepts Resubmitted BLA for Sanfilippo Syndrome

Ultragenyx Pharmaceutical jumps 5% as the FDA accepts UX111 BLA resubmission, setting up a September 2026 decision for a potential first treatment for MPS IIIA.

Zacks Industry Outlook Highlights Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics and Avalo Therapeutics

Small drug stocks like Indivior gain traction as biotech recovery strengthens, fueled by innovation, M&A activity, and promising pipeline developments.

OCGN Completes Early Enrollment in Pivotal Stargardt Disease Study

Ocugen completes GARDian3 enrollment early as OCU410ST gene therapy targets Stargardt disease with no approved treatments. Data readouts are expected in Q3. 

5 Small Drug Stocks to Buy as Sector Recovery Gains Strength

Innovation is at its peak in the Zacks Medical-Drugs industry. INDV, CPRX, TBPH, RLMD and AVTX may prove to be good additions to one's portfolio.

Kodiak Q4 Loss Wider Than Expected, Pipeline Development in Focus

KOD posts wider Q4 loss. However, its pipeline advances, with strong phase III data for Zenkuda driving accelerated regulatory plans.

AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD

Agios Pharmaceuticals jumps 14% as it moves toward accelerated FDA approval for mitapivat in sickle cell disease after key regulatory feedback.

Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company was founded on December 23, 2014 and is headquartered in North Chesterfield, VA.

INDV
Indivior Plc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INDV News

INDVIndivior Plc